Patent 8613717
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (0)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Angiodynamics Inc
No PTAB proceedings on file. This patent has not been challenged via IPR, PGR, or CBM. The absence is itself a signal — well-asserted patents eventually attract IPRs. The LLM analysis below may surface filings the ODP feed hasn’t indexed yet.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
The initial structured data indicates no AIA trial proceedings are on file for US Patent 8613717. My web search also did not surface any specific IPR, PGR, or CBM proceedings for this patent. The search results provided general information about the PTAB but no case-specific details for US8613717. Therefore, I will state that there are no PTAB proceedings.## Proceedings overview
There are no AIA trial proceedings on file for U.S. Patent 8,613,717 as of the most recent ingest. A web search for Inter Partes Review (IPR), Post-Grant Review (PGR), or Covered Business Method (CBM) proceedings related to US Patent 8,613,717 also did not yield any results. This indicates that the patent has not been challenged in an AIA trial before the Patent Trial and Appeal Board (PTAB).
Strategic summary
As of today, May 31, 2026, U.S. Patent 8,613,717 has no recorded PTAB proceedings. This means all claims (Claims 1-18) of the patent remain untested in an AIA trial context, and none have been canceled or challenged through these administrative mechanisms.
The absence of PTAB activity implies a few things for a defendant. Firstly, there are no prior art estoppel issues under 35 U.S.C. § 315(e)(2) for potential petitioners, as no IPRs have been filed. Therefore, any prior art grounds that could be raised against the patent are still available for a new petition. Secondly, the patent has not been "hardened" by surviving PTAB challenges, meaning its claims have not been reaffirmed by the Board against prior art arguments.
Recommended next steps
Since no PTAB activity exists for U.S. Patent 8,613,717, a defendant facing assertion of this patent has a full range of options should they decide to challenge its validity at the PTAB. There are no prior institution decisions or final written decisions to consider regarding claim-level outcomes or the Board's interpretation of specific prior art. This clean slate means a petitioner would be the first to present arguments against patentability in an AIA trial setting. The absence of PTAB activity is a notable signal, as well-asserted patents often become targets for IPRs.
Generated 5/31/2026, 12:46:47 AM